GS0051: A full line of pharmaceuticals, namely, pharmaceutical preparations for the treatment of alopecia, cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
Case File Event Statements
8/2/2023 - 10 months ago
4 - ASSIGNED TO EXAMINERType:DOCK
10/22/2022 - a year ago
1 - NEW APPLICATION ENTEREDType:NWAP
11/2/2022 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
6/14/2023 - 11 months ago
3 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIPType:ASGN
8/2/2023 - 10 months ago
5 - NON-FINAL ACTION WRITTENType:CNRT
8/2/2023 - 10 months ago
6 - NON-FINAL ACTION E-MAILEDType:GNRT
8/2/2023 - 10 months ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
11/1/2023 - 7 months ago
8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVEDType:XELR